⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 1, 2026Journal of Veterinary Internal MedicineOpen Access

Pilot study on the safety of swine immunoglobulin in dogs as a substitute for human intravenous immunoglobulin

Sophie R. Strome Jillian Myers Smith Namita Sinha Santosh Kumar Scott E. Strome Jin Wang Kellie Nicole Brown Elizabeth Fitzpatrick

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to assess the safety of swine immunoglobulin (SwIgG) in dogs as an alternative to human intravenous immunoglobulin (IVIG).
Pilot study design focusing on SwIgG administration in dogs.
Monitoring of safety parameters and reactions post-administration.
Assessment of SwIgG's potential as an adjunctive treatment.
SwIgG is feasible for use in dogs without significant adverse effects discovered.
Suggests further investigations into its role in treating immune-mediated disorders.

Implication

Pilot study investigates the safety of swine immunoglobulin in dogs, suggesting potential for immune-mediated disorder treatments.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Strome et al. (2026) studied this question.

synapsesocial.com/papers/69c7722a8bbfbc51511e271b https://doi.org/10.1093/jvimsj/aalag046

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Use of Human Intravenous Immunoglobulin Therapy in Two Dogs with Non-Neoplastic Bone Marrow Disorders Refractory to Immunosuppressive TherapyCase Report · 2026 · 1 citations
2Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases2024 · 1 citations
3Study on Effect of Immunoglobulins in treatment of Canine Parvovirus infected Dogs2024
4Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional studyHuman Clinical Trial · 2026
5Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: Results of In vitro and In vivo studiesOriginal Research · 2013 · 31 citations

THE POTENTIAL OF HUMAN PLASMA AND HUMAN BLOOD PRODUCTS FOR IMMUNE PROTECTION2024
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases2012
Immunological assessment and dose optimization of recombinant canine interleukin-15 following subcutaneous administration in Beagle dogs2025
Prospective evaluation of the prevalence and characteristics of heart murmurs and gallop sounds in anemic catsJournal of Veterinary Internal Medicine · 2026
Echocardiographic characteristics and evidence of ventricular remodeling in subclinical insulin-dysregulated Warmblood horsesJournal of Veterinary Internal Medicine · 2026

More from Journal of Veterinary Internal Medicine

More from University of Tennessee at Knoxville

More from University of Tennessee Health Science Center

More from Vector Oncology (United States)

More from Northwestern Medicine Lake Forest Hospital